Advertisement

Der Hautarzt

, Volume 60, Issue 2, pp 109–115 | Cite as

Bedeutung von Streptokokken für die Psoriasispathogenese

  • J.C. PrinzEmail author
Leitthema

Zusammenfassung

Infektionen durch Streptococcus pyogenes spielen unter den Umweltfaktoren, die Erstmanifestationen oder Rezidive einer Psoriasis in prädisponierten Individuen auslösen, eine besondere Rolle. Streptokokkenangina und -pharyngitis, aber auch perianale streptogene Dermatitis, streptogene Vulvovaginitis und Balanoposthitis sind mögliche Ursachen. Verschiedene Mechanismen wie molekulare Mimikry oder Superantigene sind hieran beteiligt. Viele Patienten entwickeln eine chronische Streptokokkeninfektion oder -kolonisierung, die unter anderem durch die Fähigkeit der Streptokokken zur intrazellulären Aufnahme und Persistenz in Epithelzellen bedingt ist. Ob und unter welchen Bedingungen die kurative Behandlung einer Streptokokkeninfektionen durch Tonsillektomie oder antibiotische Therapie den Verlauf einer Psoriasis beeinflussen kann, wie verschiedene Beobachtungen vermuten lassen, muss noch durch kontrollierte Studien untersucht werden.

Schlüsselwörter

Psoriasis vulgaris Streptococcus pyogenes Streptokokkeninfektion Antibiotikatherapie Tonsillektomie 

The role of streptococci in psoriasis

Abstract

Infections with Streptococcus pyogenes are highly relevant among the environmental factors that contribute to first onset or relapses of psoriasis in predisposed individuals. Streptococcal angina or pharyngitis, but also perianal streptococcal dermatitis, vulvovaginitis or balanoposthitis are potential causes. Several mechanisms such as molecular mimicry or superantigens may be involved. Many patients develop a chronic streptococcal infection or colonization that may result from the ability of streptococci for intracellular uptake and persistence in epithelial cells. Whether and under what conditions a curative treatment of streptococcal infection by tonsillectomy or antibiotic treatment may affect the course of psoriasis, as proposed by several observations, needs to be determined in more detail by clinical trials.

Keywords

Psoriasis vulgaris Streptococcus pyogenes Streptococcal infection Antibiotic treatment Tonsillectomy 

Notes

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Ajib R, Janbazian L, Rahal E et al (2005) HLA allele associations and V-beta T-lymphocyte expansions in patients with psoriasis, harboring toxin-producing staphylococcus aureus. J Biomed Biotechnol 2005:310–315PubMedCrossRefGoogle Scholar
  2. 2.
    Baker BS, Garioch JJ, Hardman C et al (1997) Induction of cutaneous lymphocyte-associated antigen expression by group A streptococcal antigens in psoriasis. Arch Dermatol Res 289:671–676PubMedCrossRefGoogle Scholar
  3. 3.
    Baker BS, Laman JD, Powles A et al (2006) Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions. J Pathol 209:174–181PubMedCrossRefGoogle Scholar
  4. 4.
    Bingen E, Denamur E, Lambert-Zechovsky N et al (1992) DNA restriction fragment length polymorphism differentiates recurrence from relapse in treatment failures of streptococcus pyogenes pharyngitis. J Med Microbiol 37:162–164PubMedGoogle Scholar
  5. 5.
    Brook I (2002) Secondary bacterial infections complicating skin lesions. J Med Microbiol 51:808–812PubMedGoogle Scholar
  6. 6.
    Cue D, Dombek PE, Lam H, Cleary PP (1998) Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells. Infect Immun 66:4593–4601PubMedGoogle Scholar
  7. 7.
    Cunningham MW (2008) Pathogenesis of group a streptococcal infections and their sequelae. Adv Exp Med Biol 609:29–42PubMedCrossRefGoogle Scholar
  8. 8.
    Diluvio L, Vollmer S, Besgen P et al (2006) Identical TCR beta-chain rearrangements in streptococcal angina and skin lesions of patients with psoriasis vulgaris. J Immunol 176:7104–7111PubMedGoogle Scholar
  9. 9.
    Dogan B, Karabudak O, Harmanyeri Y (2008) Antistreptococcal treatment of guttate psoriasis: a controlled study. Int J Dermatol 47:950–952PubMedCrossRefGoogle Scholar
  10. 10.
    England RJ, Strachan DR, Knight LC (1997) Streptococcal tonsillitis and its association with psoriasis: a review. Clin Otolaryngol Allied Sci 22:532–535PubMedCrossRefGoogle Scholar
  11. 11.
    Facinelli B, Spinaci C, Magi G et al (2001) Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet 358:30–33PubMedCrossRefGoogle Scholar
  12. 12.
    Falagas ME, Vouloumanou EK, Matthaiou DK et al (2008) Effectiveness and safety of short-course vs long-course antibiotic therapy for group a beta hemolytic streptococcal tonsillopharyngitis: a meta-analysis of randomized trials. Mayo Clin Proc 83:880–889PubMedCrossRefGoogle Scholar
  13. 13.
    Fitoussi F, Cohen R, Brami G et al (1997) Molecular DNA analysis for differentiation of persistence or relapse from recurrence in treatment failure of streptococcus pyogenes pharyngitis. Eur J Clin Microbiol Infect Dis 16:233–237PubMedCrossRefGoogle Scholar
  14. 14.
    Fry L, Baker BS (2007) Triggering psoriasis the role of infections and medications. Clin Dermatol 25:606–615PubMedCrossRefGoogle Scholar
  15. 15.
    Fry L, Powles AV, Corcoran S et al (2006) HLA Cw*06 is not essential for streptococcal-induced psoriasis. Br J Dermatol 154:850–853PubMedCrossRefGoogle Scholar
  16. 16.
    Gudjonsson JE, Karason A, Antonsdottir AA et al (2002) HLA-Cw6-positive and HLA-Cw6-negative patients with psoriasis vulgaris have distinct clinical features. J Invest Dermatol 118:362–365PubMedCrossRefGoogle Scholar
  17. 17.
    Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B et al (2003) Streptococcal throat infections and exacerbation of chronic plaque psoriasis a prospective study. Br J Dermatol 149:530–534PubMedCrossRefGoogle Scholar
  18. 18.
    Guilherme L, Fae K, Oshiro SE, Kalil J (2005) Molecular pathogenesis of rheumatic fever and rheumatic heart disease. Expert Rev Mol Med 7:1–15PubMedCrossRefGoogle Scholar
  19. 19.
    Henderson CA, Highet AS (1988) Acute psoriasis associated with Lancefield Group C and Group G cutaneous streptococcal infections. Br J Dermatol 118:559–561PubMedCrossRefGoogle Scholar
  20. 20.
    Hone SW, Donnelly MJ, Powell F, Blayney AW (1996) Clearance of recalcitrant psoriasis after tonsillectomy. Clin Otolaryngol Allied Sci 21:546–547PubMedCrossRefGoogle Scholar
  21. 21.
    Kaplan EL, Ferrieri P, Wannamaker LW (1974) Comparison of the antibody response to streptococcal cellular and extracellular antigens in acute pharyngitis. J Pediatr 84:21–28PubMedCrossRefGoogle Scholar
  22. 22.
    Komine M, Tamaki K (2000) An open trial of oral macrolide treatment for psoriasis vulgaris. J Dermatol 27:508–512PubMedGoogle Scholar
  23. 23.
    Leung DY, Gately M, Trumble A et al (1995) Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med 181:747–753PubMedCrossRefGoogle Scholar
  24. 24.
    Leung DY, Harbeck R, Bina P et al (1993) Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 92:1374–1380PubMedCrossRefGoogle Scholar
  25. 25.
    Mallbris L, Larsson P, Bergqvist S et al (2005) Psoriasis phenotype at disease onset clinical characterization of 400 adult cases. J Invest Dermatol 124:499–504PubMedCrossRefGoogle Scholar
  26. 26.
    Mallon E, Bunce M, Savoie H et al (2000) HLA-C and guttate psoriasis. Br J Dermatol 143:1177–1182PubMedCrossRefGoogle Scholar
  27. 27.
    McMillin BD, Maddern BR, Graham WR (1999) A role for tonsillectomy in the treatment of psoriasis? Ear Nose Throat J 78:155–158PubMedGoogle Scholar
  28. 28.
    Menssen A, Trommler P, Vollmer S et al (1995) Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol 155:4078–4083PubMedGoogle Scholar
  29. 29.
    Molinari G, Chhatwal GS (1999) Streptococcal invasion. Curr Opin Microbiol 2:56–61PubMedCrossRefGoogle Scholar
  30. 30.
    Molinari G, Rohde M, Guzman CA, Chhatwal GS (2000) Two distinct pathways for the invasion of Streptococcus pyogenes in non-phagocytic cells. Cell Microbiol 2:145–154PubMedCrossRefGoogle Scholar
  31. 31.
    Norrlind R (1955) The significance of infections in the origination of psoriasis. Acta Rheumatol Scand 1:135–144PubMedGoogle Scholar
  32. 32.
    Nyfors A, Rasmussen PA, Lemholt K, Eriksen B (1975) Improvement of refractory psoriasis vulgaris after tonsillectomy. Dermatologica 151:216–222PubMedGoogle Scholar
  33. 33.
    Oldstone MB (1987) Molecular mimicry and autoimmune disease. Cell 50:819–820PubMedCrossRefGoogle Scholar
  34. 34.
    Osterlund A, Engstrand L (1995) DNA fingerprinting of streptococcus pyogenes from patients with recurrent pharyngotonsillitis by means of random amplified polymorphic DNA analysis. Scand J Infect Dis 27:119–121PubMedCrossRefGoogle Scholar
  35. 35.
    Osterlund A, Popa R, Nikkila T et al (1997) Intracellular reservoir of streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope 107:640–647PubMedCrossRefGoogle Scholar
  36. 36.
    Owen CM, Chalmers RJ, O’Sullivan T, Griffiths CE (2000) Antistreptococcal interventions for guttate and chronic plaque psoriasis. Cochrane Database Syst Rev CD001976Google Scholar
  37. 37.
    Owen CM, Chalmers RJ, O’Sullivan T, Griffiths CE (2001) A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis. Br J Dermatol 145:886–890PubMedCrossRefGoogle Scholar
  38. 38.
    Park HS, Francis KP, Yu J, Cleary PP (2003) Membranous cells in nasal-associated lymphoid tissue a portal of entry for the respiratory mucosal pathogen group A streptococcus. J Immunol 171:2532–2537PubMedGoogle Scholar
  39. 39.
    Patrizi A, Costa AM, Fiorillo L, Neri I (1994) Perianal streptococcal dermatitis associated with guttate psoriasis and/or balanoposthitis a study of five cases. Pediatr Dermatol 11:168–171PubMedCrossRefGoogle Scholar
  40. 40.
    Pavone P, Parano E, Rizzo R, Trifiletti RR (2006) Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham chorea, PANDAS and PANDAS variants. J Child Neurol 21:727–736PubMedCrossRefGoogle Scholar
  41. 41.
    Pichichero ME, Casey JR (2007) Systematic review of factors contributing to penicillin treatment failure in streptococcus pyogenes pharyngitis. Otolaryngol Head Neck Surg 137:851–857PubMedCrossRefGoogle Scholar
  42. 42.
    Polat M, Lenk N, Yalcin B et al (2007) Efficacy of erythromycin for psoriasis vulgaris. Clin Exp Dermatol 32:295–297PubMedCrossRefGoogle Scholar
  43. 43.
    Prinz JC (2004) Disease mimicry–a pathogenetic concept for T cell-mediated autoimmune disorders triggered by molecular mimicry? Autoimmun Rev 3:10–50PubMedCrossRefGoogle Scholar
  44. 44.
    Prinz JC, Vollmer S, Boehncke WH et al (1999) Selection of conserved TCR VDJ rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgaris. Eur J Immunol 29:3360–3368PubMedCrossRefGoogle Scholar
  45. 45.
    Raza N, Usman M, Hameed A (2007) Chronic plaque psoriasis streptococcus pyogenes throat carriage rate and therapeutic response to oral antibiotics in comparison with oral methotrexate. J Coll Physicians Surg Pak 17:717–720PubMedGoogle Scholar
  46. 46.
    Reichel O, Mayr D, Winterhoff J et al (2007) Tonsillotomy or tonsillectomy? – A prospective study comparing histological and immunological findings in recurrent tonsillitis and tonsillar hyperplasia. Eur Arch Otorhinolaryngol 264:277–284PubMedCrossRefGoogle Scholar
  47. 47.
    Rosenberg EW, Noah PW, Zanolli MD et al (1986) Use of rifampin with penicillin and erythromycin in the treatment of psoriasis. Preliminary report. J Am Acad Dermatol 14:761–764PubMedCrossRefGoogle Scholar
  48. 48.
    Saita B, Ishii Y, Ogata K et al (1979) Two sisters with guttate psoriasis responsive to tonsillectomy case reports with HLA studies. J Dermatol 6:185–189PubMedGoogle Scholar
  49. 49.
    Saxena VN, Dogra J (2005) Long-term use of penicillin for the treatment of chronic plaque psoriasis. Eur J Dermatol 15:359–362PubMedGoogle Scholar
  50. 50.
    Shet A, Kaplan EL (2002) Clinical use and interpretation of group A streptococcal antibody tests: a practical approach for the pediatrician or primary care physician. Pediatr Infect Dis J 21:420–426, quiz 427–430PubMedCrossRefGoogle Scholar
  51. 51.
    Talanin NY, Shelley WB, Raeder R et al (1997) Detection of streptococcal class I M protein in psoriasis by confocal immunofluorescent microscopy. Acta Derm Venereol 77:175–180PubMedGoogle Scholar
  52. 52.
    Talay SR, Zock A, Rohde M et al (2000) Co-operative binding of human fibronectin to Sfbl protein triggers streptococcal invasion into respiratory epithelial cells. Cell Microbiol 2:521–535PubMedCrossRefGoogle Scholar
  53. 53.
    Telfer NR, Chalmers RJ, Whale K, Colman G (1992) The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol 128:39–42PubMedCrossRefGoogle Scholar
  54. 54.
    Tervaert WC, Esseveld H (1970) A study of the incidence of haemolytic streptococci in the throat in patients with psoriasis vulgaris, with reference to their role in the pathogenesis of this disease. Dermatologica 140:282–290PubMedGoogle Scholar
  55. 55.
    Tomi NS, Kranke B, Aberer E (2005) Staphylococcal toxins in patients with psoriasis, atopic dermatitis and erythroderma and in healthy control subjects. J Am Acad Dermatol 53:67–72PubMedCrossRefGoogle Scholar
  56. 56.
    Travers JB, Hamid QA, Norris DA et al (1999) Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis. J Clin Invest 104:1181–1189PubMedCrossRefGoogle Scholar
  57. 57.
    Tsankov N, Grozdev I, Kkzandjieva J (2006) Old drug–new indication. Rifampicin in psoriasis. J Dermatolog Treat 17:18–23PubMedCrossRefGoogle Scholar
  58. 58.
    Vincent F, Ross JB, Dalton M, Wort AJ (1992) A therapeutic trial of the use of penicillin V or erythromycin with or without rifampin in the treatment of psoriasis. J Am Acad Dermatol 26:458–461PubMedCrossRefGoogle Scholar
  59. 59.
    Vollmer S, Menssen A, Prinz JC (2001) Dominant lesional T cell receptor rearrangements persist in relapsing psoriasis but are absent from nonlesional skin evidence for a stable antigen-specific pathogenic T cell response in psoriasis vulgaris. J Invest Dermatol 117:1296–1301PubMedCrossRefGoogle Scholar
  60. 60.
    Weisenseel P, Laumbacher B, Besgen P et al (2002) Streptococcal infection distinguishes different types of psoriasis. J Med Genet 39:767–768PubMedCrossRefGoogle Scholar
  61. 61.
    Weisenseel P, Prinz JC (2005) Incidental detection of S. pyogenes-DNA in psoriatic skin by PCR. Arch Dermatol Res 296:573–576PubMedCrossRefGoogle Scholar
  62. 62.
    Whyte HJ, Baughman RD (1964) Acute guttate psoriasis and streptococcal infection. Arch Dermatol 89:350–356PubMedCrossRefGoogle Scholar
  63. 63.
    Winfield JM (1916) Psoriasis as a sequel to acute inflammation of the tonsils a clinical note. J Cutan Dis 34:441–443Google Scholar

Copyright information

© Springer Medizin Verlag 2009

Authors and Affiliations

  1. 1.Klinik und Poliklinik für Dermatologie und AllergologieLudwig-Maximilians-UniversitätMünchenDeutschland

Personalised recommendations